PHARMAC has announced it will soon fund breast cancer cancer medicine trastuzumab emtansine (Kadcyla), which is needed for women with the second most common subtype, HER2 positive breast cancer. This is fantastic news!
Sue Wall-Cade and Tracy Barr-Smith are among the leaders of a push for better treatment for women with advanced breast cancer, also known as Stage 4 breast cancer. They want better drugs and a review of PHARMAC.
Women with terminal breast cancer explain what two more years of life would mean to them and their family if life-extending drugs become funded. They are calling for funding of Ibrance and Kadcyla.
17-year-old Molly Rose Mulholland expresses her extreme disappointment that Prime Minister Jacinda Ardern did not respond personally to her letter calling for funding of important medicines for advanced breast cancer.
